Reference
Huang C-Y, et al. A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer. BMC Cancer 23: No. 1, May 2023. Available from: URL: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-10909-z
Rights and permissions
About this article
Cite this article
Afatinib/Ramucirumab. Reactions Weekly 2000, 21 (2024). https://doi.org/10.1007/s40278-024-54710-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-54710-z